Literature DB >> 23301655

Phenyl linker-induced dense PEG conformation improves the efficacy of C-terminally monoPEGylated staphylokinase.

Xiaoying Xue1, Dongxia Li, Jingkai Yu, Guanghui Ma, Zhiguo Su, Tao Hu.   

Abstract

PEGylation can improve the protein efficacy by prolonging serum half-life and reducing proteolytic sensitivity and immunogenicity. However, PEGylation may decrease the bioactivity of a protein by interfering with binding of its substrate or receptors. Here, staphylokinase (SAK), a thrombolysis agent for therapy of myocardial infarction, was mono-PEGylated at the C-terminus of SAK far from its bioactive domain. Phenyl, propyl, and amyl moieties were used as linkers between SAK and polyethylene glycol (PEG), respectively. Flexible propyl and amyl linkers lead to loose conformation. In contrast, rigid and hydrophobic phenyl linker induces dense PEG conformation that can extensively shield most domains adjacent to C-terminus (e.g., the antigen epitopes and proteolytic sites) of SAK and inefficiently shield its bioactive domain. As compared with loose PEG conformation, dense PEG conformation is more efficient to maintain the bioactivity, increase the plasma half-life, and decrease the proteolytic sensitivity and immunogenicity of the PEGylated SAK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23301655     DOI: 10.1021/bm301511w

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  4 in total

1.  Recent developments in protein and peptide parenteral delivery approaches.

Authors:  Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-03

2.  Adsorption-induced changes in ribonuclease A structure and enzymatic activity on solid surfaces.

Authors:  Yang Wei; Aby A Thyparambil; Yonnie Wu; Robert A Latour
Journal:  Langmuir       Date:  2014-12-03       Impact factor: 3.882

3.  Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.

Authors:  Yanying Xu; Yueyuan Shi; Jianzhong Zhou; Wei Yang; Lei Bai; Shilei Wang; Xin Jin; Qiangsi Niu; Ailong Huang; Deqiang Wang
Journal:  Microb Cell Fact       Date:  2017-11-14       Impact factor: 5.328

Review 4.  Interferon-omega: Current status in clinical applications.

Authors:  Shi-Fang Li; Fu-Rong Zhao; Jun-Jun Shao; Yin-Li Xie; Hui-Yun Chang; Yong-Guang Zhang
Journal:  Int Immunopharmacol       Date:  2017-10-12       Impact factor: 4.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.